CLINICAL_TRIALS
trial_result
· 2016-07-12
Clinical Trial Update: Phase 2 Extension Trial in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) [Phase 2]
Summary
A Phase 2 extension study in relapsing-remitting multiple sclerosis was terminated; results were posted on 2016-07-12.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: EMD Serono | Conditions: Multiple Sclerosis | Phase 2 | Status: TERMINATED | Results posted: 2016-07-12